What is PRISM?

Parkinson’s Real World Impact assesSMent (PRISM) study is a descriptive, exploratory observational study with cross-sectional design. A pan-European survey was designed by an International Scientific Committee in collaboration with The Cure Parkinson’s Trust (a United Kingdom-based research-driven charity), aiming to evaluate the burden of Parkinson’s disease (PD), medication use, healthcare resource utilisation (HCRU) and health-related quality of life (HRQoL) of people with Parkinson’s (PwP) and their care partners TIAGO

Who is part of the PRISM Scientific Committee?

Prof. Eduardo Tolosa (Spain); Prof. Georg Ebersbach (Germany); Prof. Joaquim J. Ferreira (Portugal), Prof. Olivier Rascol (France), Prof. Angelo Antonini (Italy), Prof. Thomas Foltynie (UK), and Prof. Andrew Lees (UK) as Chair.

The database contains which type of data?

It contains data from 861 PwP and 256 care-partners, gathered from 5 European countries: Germany, Italy, Portugal, Spain and UK. Data collected includes demographics, time since diagnosis, treatment patterns, characteristics of care-partner, HCRU and the following scales: PDQ-39 (HR QoL and Motor domain); NMSQuest; Medical Outcomes Study Sexual Functioning Scale; Zarit Burden Inventory.

Can I download and use the database?

Any health care professional or academic researcher is able to download the database after reading and understanding the PRISM Data Use Agreement and PRISM Publication Policy.

Who is BIAL Pharmaceuticals?

BIAL is an innovative pharmaceutical company, dedicated to discovering, developing and commercializing medicines, mainly focusing in CNS and Cardiovascular therapeutic areas. The mission of the company is to improve people’s lives worldwide; Keeping life in mind.